Asthma Drug May Prevent Migraines

Singulaire (montelukast sodium), a commonly used asthma drug approved to treat children over 2 years of age, is reported to also prevent headaches.

Dr. Greene shares news on an asthma drug that may help with children who have migraines…

Singulaire (montelukast sodium), a commonly used asthma medicine approved to treat children over 2 years of age, is reported to prevent headaches in adults.

At the 2001 annual Congress of the International Headache Society, researchers presented a study using Singulaire to prevent headaches in children and adolescents. Everyone in the study had a greater than 50% reduction in their number of headaches while taking the medicine. Overall, the group went from an average of 15.8 headaches per month down to 3.5 monthly headaches! No side effects were reported.

Further research is needed, but these initial results are promising. Children’s migraines are often under-diagnosed and under treated. Preventing, on average, 12 significant headaches a month must have felt wonderful to these children.

Published on: July 04, 2001
About the Author
Photo of Alan Greene MD
Dr. Greene is a practicing physician, author, national and international TEDx speaker, and global health advocate. He is a graduate of Princeton University and University of California San Francisco.
Get Dr. Greene's Wellness RecommendationsSignup now to get Dr. Greene's healing philosophy, insight into medical trends, parenting tips, seasonal highlights, and health news delivered to your inbox every month.
No comments yet. Start the conversation!
Add your comment